Functional identification of an intronic promoter of the human glucose-dependent insulinotropic polypeptide gene

Gene

Volumn 463, Issue 1-2, 2010, Pages 29-40

  Hoo, Ruby L C ^a   Chu, Jessica Y S ^a   Yuan, Y ^a   Yeung, C M ^a   Chan, Kathy Y Y ^a   Chow, Billy K C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gene regulation; GIP; Intestine; Pancreas; Progesterone receptor; Transcription factor II D

Indexed keywords

CIS ACTING ELEMENT; GASTRIC INHIBITORY POLYPEPTIDE; PROGESTERONE; PROGESTERONE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA ISOLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

MUS MUSCULUS;

EID: 77954657008     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.04.017     Document Type: Article

References (57)

1. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Sediman J.G., Smith J.A., Struhi K. Current Protocols in Molecular Biology 1987, Wiley and Sons, New York.
2. Azizkhan J.C., Jensen D.E., Pierce A.J., Wade M. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 1993, 3:229-254.
3. Beck B., Max J.P. Gastric inhibitory polypeptide enhancement of the insulin effect on fatty-acid incorporation into adipose tissue in the rat. Regul. Pept. 1983, 7:3-8.
4. Bollag R.J., Zhong Q., Phillips P., Min L., Zhong L., Cameron R., Mulloy A.L., Rasmussen H., Qin F., Ding K.H., Isales C.M. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 2000, 141:1228-1235.
5. Boylan M.O., Jepeal L.I., Wolfe M.M. Cell-specific expression of the glucose-dependent insulinotropic gene in a mouse neuroendocrine tumor cell line. J. Biol. Chem. 1997, 272:17438-17443.
6. Brooks A.R., Blackhart B.D., Haubold K., Levy-Wilson B. Characterization of tissue-specific enhancer elements in the second intron of the human apolipoprotein B gene. J. Biol. Chem. 1991, 266:7848-7859.
7. Brown J.C. Gastric inhibitory polypeptide. Monographs on Endocrinology 1982, vol. 24:1-88. Springer Verlag, Berlin.
8. Brown J.C., Mutt V., Pederson R.A. Further purification of a polypeptide demonstrating enterogastrone activity. J. Physiol. 1970, 209:57-64.
9. Brown J.C., Pederson R.A., Jorpes J.E., Mutt V. Preparation of highly active enterogastrone. Can. J. Physiol. Pharmacol. 1969, 47:113-114.
10. Buchan A.M., Polak J.M., Capella C., Solcia L., Pearse A.G. Electroimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 1978, 56:37-44.
11. Cheung A.T., Dayanandan B., Lewis J.T., Korbutt G.S., Rajotte R.V., Bryer-Ash M., Boylan M.O., Wolfe M.M., Kieffer T.J. Glucose-dependent insulin release from genetically engineered K cells. Science 2000, 290:1959-1962.
12. Chow B.K., Ting V., Tufaro F., MacGillivray R.T. Characterization of a novel liver-specific enhancer in the human prothrombin gene. J. Biol. Chem. 1991, 266:18927-18933.
13. Chu J.Y., Chung S.C., Lam A.K., Tam S., Chung S.K., Chow B.K. Phenotypes developed in secretin receptor-null mice indicated a role of secretin in regulating renal water reabsorption. Mol. Cell. Biol. 2007, 27:2499-2511.
14. Clemm D.L., Macy B.L., Santiso-Mere D., McDonnell D.P. Definition of the critical cellular components which distinguish between hormone and antihormone activated progesterone receptor. J. Steroid Biochem. Mol. Biol. 1995, 53:487-495.
15. Dynlacht B.D., Hoey T., Tjian R. Isolation of coactivators associated with the TATA-binding protein that mediates transcriptional activation. Cell 1991, 66:563-576.
16. Eckel R.H., Fujimoto W.Y., Brunzell J.D. Gastric inhibitory polypeptide enhances lipoprotein lipase activity in cultured preadipocytes. Diabetes 1979, 28:1141-1142.
17. Gao J., Tseng L. Progesterone receptor (PR) inhibits expression of insulin-like growth factor-binding protein-1 (IGFBP-1) in human endometrial cell line HEC-1B: characterization of the inhibitory effect of PR on the distal promoter region of the IGFBP-1 gene. Mol. Endocrinol. 1997, 11:973-979.
18. Gill G., Pascal E., Tseng Z.H., Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the TAFs II 110 component of the Drosophila TF II D complex and mediates transcriptional activation. Proc. Natl Acad. Sci. USA 1994, 91:192-196.
19. Goodrich J.A., Tjian R. TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 1994, 6:403-409.
20. Higashimoto Y., Liddle R.A. Isolation and characterization of the gene encoding rat glucose-dependent insulinotropic peptide. Biochem. Biophys. Res. Commun. 1993, 193:182-190.
21. Hoo R.L., Ngan E.S., Leung P.C., Chow B.K. Two Inr elements are important for mediating the activity of the proximal promoter of the human gonadotropin-releasing hormone receptor gene. Endocrinology 2002, 144:518-527.
22. Hwang E.S., Choi A., Ho I.C. Transcriptional regulation of GATA-3 by an intronic regulatory region and fetal liver zinc finger protein 1. J. Immunol. 2002, 169:248-253.
23. Inagaki N., Seino Y., Takeda J., Yano H., Yamada Y., Bell C.I., Eddy R.L., Fukushima Y., Byers M.G., Shows T.B., Imura H. Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene. Mol. Endocrinol. 1989, 3:1014-1021.
24. Ing N.H., Beekman J.M., Tsai S.Y., Tsai M.J., O'Malley B.W. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 1992, 267:17617-17623.
25. Inoue T., Akahira J.I., Takeyama J., Suzuki T., Darnel A.D., Kaneko C., Kurokawa Y., Satomi S., Sasano H. Spatial and topological distribution of progesterone receptor A and B isoforms during human development. Mol. Cell. Endocrinol. 2001, 182:83-89.
26. Jepeal L.I., Boylan M.O., Wolfe M.M. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line. Regul. Pept. 2003, 113:139-147.
27. Jung M., Dritschilo A., Mark G., Kasid U. Identification of multiple repeat sequences and transcription-related elements within introns 4, 8 and 9 of human RAF-1. Biochem. Biophys. Res. Commun. 1993, 190:462-469.
28. Kieffer T.J., Buchan A.M., Barker H., Brown J.C., Pederson R.A. Release of gastric inhibitory polypeptide from cultured canine endocrine cells. Am. J. Physiol. 1994, 267:E489-E496.
29. Klein-Hitpass L., Tsai S.Y., Weigel N.L., Allan G.F., Riley D., Rodriguez R., Schrader W.T., Tsai M.J., O'Malley B.W. The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell 1990, 60:247-257.
30. Lee K., Bindereif A., Green M.R. A small scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 1988, 5:22-31.
31. Lin C.S., Chow S., Lau A., Tu R., Lue T.F. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int. J. Impot. Res. 2002, 14:15-24.
32. Maniatis T., Fritsch E.F., Sambrook J. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
33. Morgan L.M. The metabolic role of GIP: physiology and pathology. Biochem. Soc. Trans. 1996, 24:585-591.
34. Mueller M.D., Vigne J.L., Pritts E.A., Chao V., Dreher E., Taylor R.N. Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertil. Steril. 2003, 79:386-392.
35. Nauck M., Schmidt W.E., Ebert R., Strietzel J., Cantor P., Hoffmann G., Creutzfeldt W. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J. Clin. Endocrinol. Metab. 1989, 69:654-662.
36. Owen G.I., Richer J.K., Tung L., Takimoto G., Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 1998, 273:10696-10701.
37. Pederson R.A. Gastric inhibitory polypeptide. Gut Peptides: Biochemistry and Physiology 1994, Raven Press, New York. J.H. Walsh, G.J. Dockray (Eds.).
38. Picard F., Wanatabe M., Schoonjans K., Lydon J., O'Malley B.W., Auwerx J. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta-cell proliferation. Proc. Natl Acad. Sci. USA 2002, 99:15644-15648.
39. Polak J.M., Bloom S.R., Kuzio M., Brown J.C., Pearse G.E. Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum. Gut 1973, 14:284-288.
40. Pugh B.F., Tjian R. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 1990, 61:1187-1197.
41. Schwerk C., Klotzbucher M., Sachs M., Ulber V., Klein-Hitpass L. Identification of a transactivation function in the progesterone receptor that interacts with the TAFII110 subunit of the TFIID complex. J. Biol. Chem. 1995, 270:21331-21338.
42. Siebert P.D., Chenchik A. Modified acid guandinium thio-cyanate-phenol-chloroform RNA extraction method which greatly reduces DNA contamination. Nucleic Acids Res. 1993, 21:2019-2020.
43. Someya Y., Inagaki N., Maekawa T., Seino Y., Ishii S. Two 3', 5'-cyclic adenosine monophosphate response elements in the promoter region of human gastric inhibitory polypeptide gene. FEBS Lett. 1993, 317:67-73.
44. Starich G.H., Bar R.S., Mazzaferri E.L. GIP increases insulin receptor affinity and cellular sensitivity in adipocytes. Am. J. Physiol. 1985, 249:E603-E607.
45. Takemura J., Seino Y., Tsuda K., Seino S., Ikeda M., Sakurai H., Imura H. Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus. Endocrinol. Jpn 1981, 28:17-21.
46. Tanese N., Pugh B.F., Tjian R. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev. 1991, 5:2212-2224.
47. Tasheva E.S. Analysis of the promoter region of human mimecan gene. Biochim. Biophys. Acta 2002, 1575:123-129.
48. Thomas F.B., Shook D.F., O'Dorisio T.M., Cataland S., Mekhjian H.S., Caldwell J.H., Mazzaferri E.L. Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology 1977, 72:49-54.
49. Trumper A., Trumper K., Trusheim H., Arnold R., Goke B., Horsch D. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol. Endocrinol. 2001, 15:1559-1570.
50. Tseng C.C., Jorboe L.A., Landau S.B., Williams E.K., Wolfe M.M. Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat. Proc. Natl Acad. Sci. USA 1993, 90:1992-1996.
51. Wieczorek E., Lin Z., Perkins E.B., Law D.J., Merchant J.L., Zehner Z.E. The zinc finger repressor, ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Sp1. J. Biol. Chem. 2000, 275:12879-12888.
52. Yamada M., Yoshida M., Hashinaka K. Identification of transcriptional cis-elements in intron 7 and 9 of the myeloperoxidase gene. J. Biol. Chem. 1993, 268:13479-13485.
53. Yeh T.S., Jan Y.Y., Chiu C.T., Ho Y.B., Chen T.C., Lee K.F., Chan K.M., Hsu J.C., Hwang T.L., Chen M.F. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma. Gut 2002, 51:712-716.
54. Yeung C.M., Wong C.K.C., Chung S.K., Chung S.S.M., Chow B.K.C. Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by transgenic mouse study, in situ hybridization and immunohistochemical staining. Mol. Cell. Endocrinol. 1999, 154:161-170.
55. Yip R.G., Wolfe M.M. GIP biology and fat metabolism. Life Sci. 2000, 66:91-103.
56. Zaidi M., Alam A.S., Shankar V.S., Bax B.E., Bax C.M., Moonga B.S., Bevis P.J., Stevens C., Blake D.R., Pazianas M. Cellular biology of bone resorption. Biol. Rev. Camb. Philos. Soc. 1993, 68:197-264.
57. Zhou Q., Lieberman P.M., Boyer T.G., Berk A.J. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. Genes Dev. 1992, 6:1964-1974.